ClinicalTrials.Veeva

Menu

Factors Influencing Morbi-mortality in Right Anterior Minithoracotomy Approch for Aortic Valve Replacement (RVAOMITAVA)

C

Centre Hospitalier La Chartreuse

Status

Completed

Conditions

Aortic Valve Disease

Treatments

Procedure: Aortic valve replacement

Study type

Observational

Funder types

Other

Identifiers

NCT04455165
CCVT-RVAoMITAVARegistry

Details and patient eligibility

About

Since 2009, positive experiences with right anterior minithoracotomy as an approach to aortic valve replacement are extensively practiced in our institution. The primary disease process for which patients are referred remains aortic stenosis. But more and more, we met older patients with both aortic stenosis and other cardiac pathology (coronary artery disease, other valvulopathy...). Even if minimally invasive valve surgery has been demonstrated to significantly improve postoperative course (reduced blood transfusion, pain, hospital lengths of stay) and to enhance postoperative recovery, when compared with a median sternotomy, it is however important to have medical data and statistics in order to better understand the factors influencing morbi-mortality and thereby to continue this improvement.

Enrollment

300 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients > 18 y-o who underwent aortic valve replacement

Exclusion criteria

  • None

Trial design

300 participants in 1 patient group

RVAo MITAVA
Description:
Patient operated since 2009 for aortic valve replacement through right anterior minithoracotomy approch in Dijon Burgundy University Hospital
Treatment:
Procedure: Aortic valve replacement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems